Accordingly, RQ-PCR analysis of NOMO-1 demonstrated decreased expression of HLX after treatment with TSA and STAT3-inhibitor doxorubicine as well (Fig 7B), indicating that both NANOG and HLX are regulated by STAT3 in this AML cell line. The gene discussed is STAT3; the disease is acute myeloid leukemia.